Dr.Jurgi Camblong is one of the most visionary entrepreneurs in the fast growing domain of clinical genomics. After a successful academic career in Molecular Biology he moved to the Start-up scene with the objective of making genomics a reality for improved patients' diagnosis and care. After acting as the CEO of Gene Predictis, he founded Sophia Genetics in 2011 with Dr. Pierre Hutter and Prof. Lars Steinmetz. Since then Dr. Camblong has been successfully leading the development of the company, recruiting the right talents and executing innovative business models. Today, he is considered as one of the most successful Swiss entrepreneurs. Jurgi Camblong holds a PhD in Life Sciences (University of Geneva) and an EMBA in Management of Technology (EPFL-HEC Lausanne).degree at the École Polytechnique Fédérale de Lausanne.
clinical genomics, genomics, Molecular Biology